Dermatology drug pipeline

Psoriasis, atopic dermatitis, acne, vitiligo, and other dermatological therapeutics.

Recent approvals (last 30 days)

No approvals in this window.

Upcoming PDUFA dates (next 6 months)

No upcoming decisions in this window.

Top sponsors

1. Galderma R&D · 77 drugs
2. LEO Pharma · 48 drugs
3. · 42 drugs
4. Pfizer · 21 drugs
5. Bausch Health Americas, Inc. · 20 drugs
6. Stiefel, a GSK Company · 18 drugs
7. Actavis Inc. · 14 drugs
8. Allergan · 12 drugs
9. GlaxoSmithKline · 11 drugs
10. Bayer · 10 drugs

Key drug classes

• Topical corticosteroid · 36
• Retinoid · 30
• Corticosteroid · 30
• Botulinum toxin · 23
• Topical antibiotic combination · 15
• Imidazole antifungal · 14
• Phosphodiesterase 4 (PDE4) inhibitor · 14
• Retinoid + peroxide combination · 11
• Allylamine antifungal · 10
• Botulinum toxin type A · 9
• Photodynamic therapy agent · 9
• Corticosteroid (glucocorticoid) · 9
• Calcineurin inhibitor · 8
• Topical corticosteroid (Class I/super-potent) · 8
• corticosteroid · 8

Major diseases in this area

• psoriasis
• atopic dermatitis

Subscribe

Get dermatology approvals + PDUFA dates in your RSS reader:

• Dermatology RSS feed · Atom · JSON

Other therapeutic areas